Default company panoramic image

Aquarius Biotechnologies

Aquarius uses a drug delivery technology to allow oral delivery of drugs that are now only available via IV, and reduce drug toxicity.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Chicago, IL, USA
  • Currency USD
  • Founded June 2012
  • Employees 5
  • Website

Company Summary

Many drugs exist that are effective in treating diseases, but are difficult and expensive to administer with existing technology. In addition, many of these drugs are highly toxic and have a short shelf-life. Aquarius' technology, called "cochleate" technology, solves these problems by delivering the drugs more cheaply and effectively with less toxicity. Aquarius partners with pharma and biotech companies to develop drugs using the technology.


  • Default avatar
    Raphael Thomas Mannino
    Chief Executive Officer

    7 years general management experience
    Former Associate, Hyde Park Angels and Hyde Park Venture Partners
    MBA (in progress), University of Chicago Booth School of Business
    B.A. Mathematics, Columbia University

  • Default avatar
    Raphael James Mannino
    Chief Scientific Officer

    Inventor of cochleate technology
    Founder of biotech company that is now publicly traded
    Professor, University of Medicine and Dentistry of New Jersey
    Ph.D. in Biological Chemistry, Johns Hopkins School of Medicine

  • Default avatar
    Carl Craft
    Chief Medical Officer

    Designed over 100 clinical trials
    15+ yrs leading anti-infective unit at Abbott Laboratories
    Scientific Advisory Board, Drugs for Neglected Disease Initiative

  • Default avatar
    Ruying Lu
    Chief Formulations Scientist

    World’s foremost expert in cochleate formulation (15+ years)
    Inventor on 5 issued patents
    Graduate of Shanghai Second Medical University

  • Default avatar
    Susan Bonitz
    Chief Development Officer

    20 years experience with start-ups and big pharma
    10+ years working with government agencies to secure grants
    Ph.D. in Molecular Biology, Columbia University


  • Default avatar
    McCarter & English